Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2007-11-13
pubmed:abstractText
Combined pegylated interferon and ribavirin has improved chronic hepatitis C (CH-C) therapy; however, sustained virological response is achieved in only about half of the patients with a 1b genotype infection. We assessed oral ursodeoxycholic acid (UDCA) on serum biomarkers as a possible treatment for interferon non-responders.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1468-3288
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
56
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1747-53
pubmed:dateRevised
2011-3-1
pubmed:meshHeading
pubmed-meshheading:17573387-Adult, pubmed-meshheading:17573387-Aged, pubmed-meshheading:17573387-Alanine Transaminase, pubmed-meshheading:17573387-Aspartate Aminotransferases, pubmed-meshheading:17573387-Bile Acids and Salts, pubmed-meshheading:17573387-Biological Markers, pubmed-meshheading:17573387-Cholagogues and Choleretics, pubmed-meshheading:17573387-Dose-Response Relationship, Drug, pubmed-meshheading:17573387-Double-Blind Method, pubmed-meshheading:17573387-Female, pubmed-meshheading:17573387-Hepacivirus, pubmed-meshheading:17573387-Hepatitis C, Chronic, pubmed-meshheading:17573387-Humans, pubmed-meshheading:17573387-Male, pubmed-meshheading:17573387-Middle Aged, pubmed-meshheading:17573387-Treatment Outcome, pubmed-meshheading:17573387-Ursodeoxycholic Acid, pubmed-meshheading:17573387-Viral Load, pubmed-meshheading:17573387-gamma-Glutamyltransferase
pubmed:year
2007
pubmed:articleTitle
A large-scale, multicentre, double-blind trial of ursodeoxycholic acid in patients with chronic hepatitis C.
pubmed:affiliation
Department of Gastroenterology, University of Tokyo Graduate School of Medicine, Hongo 7-3-1, Bunkyo, Tokyo 113-8655, Japan. omata-2im@h.u-tokyo.ac.jp
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Multicenter Study